Clinical Trials Directory

Trials / Completed

CompletedNCT02883413

Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa

An Investigation of Cognitive Remediation Therapy as an Inpatient Intervention for Adolescents With Anorexia Nervosa

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the current study is to investigate the role of Cognitive Remediation Therapy (CRT) as a pre-treatment intervention for adolescents who are hospitalized for Anorexia Nervosa (AN). The primary aims are to determine if CRT can result in greater treatment engagement post-discharge, increased rate of weight gain post-discharge, reduction in symptom accommodation, and increased behavioral flexibility in adolescents and parents.

Detailed description

Anorexia Nervosa (AN) is a severe psychiatric condition; the hallmark features are low body weight and difficulties gaining weight. We are in need of new methods to jump start treatment, while targeting relevant processes in individuals with AN. Study Design: This is a randomized controlled trial looking to address these concerns, with a focus on three distinct aims: 1. To evaluate the feasibility and acceptability (by patients and staff) of CRT in a medical hospitalization setting. 2. Compare the impact of CRT to CRT + Teach the Parent on adolescent treatment engagement post-discharge, rate of weight gain post-discharge, and reduction of symptom accommodation. 3. To evaluate cognitive and behavioral flexibility 6 months post-discharge. Setting/Participants: Participants will be 60 adolescents with AN or subclinical AN (and their parents). Adolescents will be hospitalized for treatment of AN and intervention will occur on an inpatient basis. Follow-up will be outpatient. Study Interventions and Measures: The current study will investigate the impact of intensive CRT (one sessions/day) delivered during in hospital for medical stabilization. Shortly after admission to hospital, adolescents will be randomly assigned to one of the following conditions: Treatment as usual (TAU), CRT+Contact Control (known as "Family Fun Time" or FFT) and CRT + Teach the Parent. Psychosocial, neurocognitive, and behavioral measures will be collected throughout the study. Follow-up will continue for 6 months post-discharge. Description of Investigational Intervention: CRT is an adjunctive intervention focusing on the development of meta-cognition: Teaching individuals to think about how they think. It involves presenting individuals with a variety of tasks requiring increasingly complex mental abilities. These include sorting tasks where rules change, geometric figures, illusions, reversing sequences of numbers and letters, and finding various routes on a map. CRT's focus is mainly on process, instead outcome, and has three main goals: 1. Improve brain function by exercising and increasing connections in the brain 2. Encourage individuals to think about their thinking style 3. Encourage individuals and families to spend time away from thinking about the eating disorder

Conditions

Interventions

TypeNameDescription
BEHAVIORALCRT + Teach the ParentCRT sessions will occur for 45-60 minutes every day (excluding weekends) for 6-8 days while adolescents are in hospital. Adolescents will be given homework and asked to practice tasks each day.
BEHAVIORALCRT + Contact ControlAdolescents will be asked to spend 3-4 sessions with their parents engaging in fun activities (games, coloring, trivia). Adolescents will be able to choose 2 tasks from a list and be asked to engage in those tasks with their parents.

Timeline

Start date
2016-08-01
Primary completion
2017-11-16
Completion
2017-11-16
First posted
2016-08-30
Last updated
2019-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02883413. Inclusion in this directory is not an endorsement.

Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa (NCT02883413) · Clinical Trials Directory